Abraa güvenli ticaret sistemlerini kullanarak güvenli ve emniyetli ödemeler Ürün Özellikleri
| Novodisk | |
| 98 | |
| Medicine Grade | |
| Other |
Product Descriptions
Weight loss injections, primarily GLP-1 agonists like semaglutide (Wegovy, Ozempic) and liraglutide, are used for chronic weight management in people with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with weight-related conditions, helping reduce appetite, slow digestion (feeling fuller longer), and decrease calorie intake, leading to significant weight loss, often alongside diet/exercise. They mimic a natural gut hormone (GLP-1) to control hunger and blood sugar, and can also lower risks for heart attack, stroke, and fatty liver disease
\
